Torrent Pharmaceuticals announced that it has entered into an agreement to acquire three anti-diabetes brands from Boehringer Ingelheim International GmbH (BI). The brands include Cospiaq (empagliflozin), Cospiaq Met...
Pharmaceutical
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
U.S.-based vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in the Czech Republic to Wegovy maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline. Novavax...
Novo Holdings set to win EU nod for $16.5 bln Catalent deal, source says
Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S. contract drug maker Catalent, a person with direct knowledge of the matter said on Friday, clearing a key...
360 ONE Asset acquires stake in OneSource Specialty Pharma
Asset management firm 360 ONE Asset on Thursday said it has invested in OneSource Specialty Pharma, a fast-growing Contract Development and Manufacturing Organization (CDMO) by acquiring a stake from an existing...
National Company Law Tribunal clears Casper Pharma’s merger with Suven Pharmaceuticals
The Mumbai bench of the National Company Law Tribunal (NCLT) has approved Casper Pharma’s merger with listed drug maker, Suven Pharmaceuticals. In April 2022, Suven Pharmaceuticals acquired Casper Pharma (CPPL) for...
Strides Pharma Global, Singapore to acquire balance 30% stake in Strides Switzerland
Strides Pharma Global, Singapore (SPG), a wholly owned step-down subsidiary of Strides Pharma Science, is acquiring a balance stake in Strides Pharma International AG (formerly Fairmed Healthcare AG) (Strides...
Mankind Pharma completes Rs 13,768 cr BSV acquisition
Mankind Pharma on Wednesday said it has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of Rs 13,768 crore. This strategic move marks a significant leap for the company...
EMS bids for rival Hypera to create Brazil’s largest drugmaker
Brazilian pharmaceutical company EMS has offered to join forces with rival Hypera to create the country’s biggest drug manufacturer, they said on Monday. In a securities filing, Hypera said its board will assess...
Quadria, TPG eye up to 25% stake for $100 mn in Samarth Life Sciences
Private equity investors including Quadria Capital and TPG Capital have expressed initial interest to invest about $100 million for a 20-25% stake in critical care drugs provider Samarth Life Sciences, three people...
Cipla, Alkem Laboratories in final lap to buy SMT
Drugmakers Cipla and Alkem Laboratories have emerged as the frontrunners to acquire a controlling stake in Sahajanand Medical Technologies (SMT), India’s largest cardiac stent maker, said people in the know. This...
France considering stake in Sanofi’s Opella, minister says
France is considering taking a stake in Sanofi’s Opella arm, said finance minister Antoine Armand, to allay concerns that the French drugmaker’s plans to sell a 50% stake in Opella to a U.S. private equity...
Vanda Pharmaceuticals rejects Cycle Pharma’s second takeover offer
Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share despite a drop in Vanda’s stock following the FDA’s...
